Reduced-Dose Trimethoprim-Sulfamethoxazole Effective in Treating Mild to Moderate Pneumocystis jirovecii PneumoniaByKyle Crooker, MD,Eleanor Stedman, MD,Sean S. M. Bullis, MD,Andrew J. Hale, MDSeptember 20th 2022Here is a review of using this therapy in this patient population.
Is There a Better Choice Than TMP-SMX to Treat Stenotrophomonas maltophilia Infections?ByKyle Crooker, MD,Sean S. M. Bullis, MD,Andrew J. Hale, MDDecember 16th 2021